Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis

NCT00075621 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: filgrastim
DRUG: melphalan
PROCEDURE: autologous peripheral blood stem cell transplantation

Sponsor

Boston Medical Center